Short, sourced explanations of the terms, rules, and measures behind breast imaging operations. Each one covers what it is, how it works, and why it matters.
The FDA says most ruptures of silicone gel-filled breast implants are silent. They usually do not change how the implant looks or feels.
How it works
A physical examination alone may not find a silent rupture. The FDA's page says magnetic resonance imaging (MRI) is the most effective method for detecting silent rupture of silicone gel-filled implants, and that ultrasound is an acceptable alternative imaging method for screening for rupture in patients without symptoms. The ultrasound statement was added in the December 2023 update. The page does not state how often to image; patients are directed to their surgeon or health care provider.
Why it matters
The longer an implant is in place, the greater the chance it may rupture, so imaging questions belong in a patient's conversation with their surgeon. Imaging for implant rupture is a different purpose from cancer screening.
What it means to the patient or the client
For patients with silicone gel implants: a rupture may cause no symptoms, so MRI is the most effective way to find one, and ultrasound is an acceptable alternative if you have no symptoms. Ask your surgeon or health care provider how often to be imaged, because the FDA page does not give a schedule.
Sources
US Food and Drug Administration. Risks and complications of breast implants. Content current as of December 15, 2023. Accessed October 7, 2026. https://www.fda.gov/medical-devices/breast-implants/risks-and-complications-breast-implants View source (accessed October 7, 2026)
The American Cancer Society recommends screening mammography on a schedule that depends on age for women at average risk of breast cancer. This is a professional society recommendation, not a federal regulation.
How it works
Women ages 40 to 44 have the option to start screening with a mammogram every year. Women 45 to 54 should get mammograms every year. Women 55 and older can switch to a mammogram every other year, or continue yearly mammograms. The ACS does not recommend clinical breast exams for breast cancer screening in average risk women at any age.
Why it matters
Different groups, such as the U.S. Preventive Services Task Force, recommend different starting ages and intervals, so patient materials should say which recommendation they follow. The page was last revised July 23, 2026.
What it means to the patient or the client
For patients: the ACS schedule depends on your age, and other groups recommend different starting ages and intervals, so ask your healthcare provider which one fits you. For the client: say in patient materials which recommendation you follow.
Sources
American Cancer Society. American Cancer Society recommendations for the early detection of breast cancer. Last revised July 23, 2026. Accessed October 7, 2026. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html View source (accessed October 7, 2026)
The American Cancer Society recommends a breast MRI and a mammogram every year for women at high risk of breast cancer, typically starting at age 30. This is a professional society recommendation.
How it works
The ACS places in the high risk group women with a lifetime risk of about 20% to 25% or greater according to risk assessment tools that rely mainly on family history, women with a known BRCA1 or BRCA2 mutation, untested first degree relatives of carriers, women who had chest radiation therapy before age 30, and women with Li-Fraumeni, Cowden, or Bannayan-Riley-Ruvalcaba syndrome. It recommends against MRI screening for women whose lifetime risk is less than 15%, and says evidence is insufficient for women at 15% to 20%.
Why it matters
Risk assessment is what places a woman in the high risk group, so a facility that offers supplemental MRI needs a documented way to assess lifetime risk. Other groups, such as the NCCN, publish their own recommendations.
What it means to the patient or the client
For patients: if you have a strong family history, a known BRCA mutation, or had chest radiation before age 30, ask your healthcare provider whether you are in the higher risk group. For the client: offering supplemental MRI needs a documented way to assess lifetime risk.
Sources
American Cancer Society. American Cancer Society recommendations for the early detection of breast cancer. Last revised July 23, 2026. Accessed October 7, 2026. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html View source (accessed October 7, 2026)
